Revolution Medicines Poster Presentations: Adaptive Immunity in Tumors / Oncogenic Pathway-Mediated Regulation of Inflammation and Tumor Immunity April 29; 3:25 p.m. – 3:40 p.m. CST ...
Biomea Fusion, Inc. (“Biomea” or the “Company”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity medicines company, today announced that on March 23, 2025, the compensation committee of Biomea’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback